INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:INSP • US4577301090

65.7 USD
+0.1 (+0.15%)
At close: Feb 6, 2026
66.65 USD
+0.95 (+1.45%)
After Hours: 2/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, INSP scores 6 out of 10 in our fundamental rating. INSP was compared to 186 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • INSP had positive earnings in the past year.
  • In the past year INSP had a positive cash flow from operations.
  • In the past 5 years INSP reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • With an excellent Return On Assets value of 5.52%, INSP belongs to the best of the industry, outperforming 82.80% of the companies in the same industry.
  • INSP has a Return On Equity of 6.69%. This is amongst the best in the industry. INSP outperforms 81.72% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.82%, INSP is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
Industry RankSector Rank
ROA 5.52%
ROE 6.69%
ROIC 4.82%
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.05%, INSP is in the better half of the industry, outperforming 77.96% of the companies in the same industry.
  • INSP's Operating Margin of 4.16% is fine compared to the rest of the industry. INSP outperforms 68.82% of its industry peers.
  • INSP has a Gross Margin of 84.92%. This is amongst the best in the industry. INSP outperforms 94.62% of its industry peers.
  • In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
Industry RankSector Rank
OM 4.16%
PM (TTM) 5.05%
GM 84.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, INSP has more shares outstanding
  • INSP has more shares outstanding than it did 5 years ago.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 9.57 indicates that INSP is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of INSP (9.57) is better than 88.71% of its industry peers.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.57
ROIC/WACC0.48
WACC10.08%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
  • INSP has a better Current ratio (5.29) than 80.65% of its industry peers.
  • A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
  • INSP has a Quick ratio of 4.01. This is in the better half of the industry: INSP outperforms 75.81% of its industry peers.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 4.01
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 90.65% over the past year.
  • INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.81%.
  • Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 57.78% on average per year.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%

3.2 Future

  • INSP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.80% yearly.
  • The Revenue is expected to grow by 11.14% on average over the next years. This is quite good.
EPS Next Y-14.92%
EPS Next 2Y0.95%
EPS Next 3Y14.05%
EPS Next 5Y18.8%
Revenue Next Year13.53%
Revenue Next 2Y12.1%
Revenue Next 3Y11.94%
Revenue Next 5Y11.14%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 32.21, which means the current valuation is very expensive for INSP.
  • 73.12% of the companies in the same industry are more expensive than INSP, based on the Price/Earnings ratio.
  • INSP is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 37.27, which means the current valuation is very expensive for INSP.
  • INSP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 70.43% of the companies in the same industry.
  • INSP's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 32.21
Fwd PE 37.27
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than 71.51% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, INSP is valued cheaper than 89.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.32
EV/EBITDA 27.91
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • INSP's earnings are expected to grow with 14.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.95%
EPS Next 3Y14.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for INSP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (2/6/2026, 8:04:00 PM)

After market: 66.65 +0.95 (+1.45%)

65.7

+0.1 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12
Earnings (Next)02-11
Inst Owners111.59%
Inst Owner Change-0.27%
Ins Owners0.74%
Ins Owner Change0.1%
Market Cap1.91B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts80
Price Target131.09 (99.53%)
Short Float %10.28%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-9.17%
PT rev (3m)3.12%
EPS NQ rev (1m)31.97%
EPS NQ rev (3m)30.73%
EPS NY rev (1m)39.14%
EPS NY rev (3m)185.48%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 32.21
Fwd PE 37.27
P/S 2.16
P/FCF 19.32
P/OCF 14.28
P/B 2.86
P/tB 2.86
EV/EBITDA 27.91
EPS(TTM)2.04
EY3.11%
EPS(NY)1.76
Fwd EY2.68%
FCF(TTM)3.4
FCFY5.18%
OCF(TTM)4.6
OCFY7%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
Industry RankSector Rank
ROA 5.52%
ROE 6.69%
ROCE 5.27%
ROIC 4.82%
ROICexc 8.98%
ROICexgc 8.98%
OM 4.16%
PM (TTM) 5.05%
GM 84.92%
FCFM 11.2%
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 276.46%
Cap/Sales 3.95%
Interest Coverage 250
Cash Conversion 270.95%
Profit Quality 221.78%
Current Ratio 5.29
Quick Ratio 4.01
Altman-Z 9.57
F-Score8
WACC10.08%
ROIC/WACC0.48
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-14.92%
EPS Next 2Y0.95%
EPS Next 3Y14.05%
EPS Next 5Y18.8%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.53%
Revenue Next 2Y12.1%
Revenue Next 3Y11.94%
Revenue Next 5Y11.14%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year658.15%
EBIT Next 3Y123.39%
EBIT Next 5Y70.56%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.


What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 32.21 and the Price/Book (PB) ratio is 2.86.


What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.